Syngene International Ltd Company History

Initiated operations as a CRO with services in chemistry and biology

Granted 100% Export Oriented Unit (EOU) status by the Government of India

First operational expansion in R&D by way of expansion of lab space to over 23,000 sq. ft.

CIL was incorporated as a 100% subsidiary of Biocon to provide clinical research services to domestic and multinational companies

Forayed into chemical development with a dedicated manufacturing facility

Moved to Biocon Park, a 90 acre biopharmaceutical SEZ with operations spread over 65,000 sq. ft.

Bristol-Myers Squibb and the Company signed the first long term contract to set up the first dedicated R&D centre

Expansion of research facilities at Biocon SEZ to 148,000 sq. ft.

Crossed an annual turnover of over `1,000 million in Financial Year 2007

Dupont Crop Protection and the Company extended a partnership for R&D services

Expansion of manufacturing services with a new plant which is cGMP compliant

Initiated operations in safety assessment and large molecules development services

Bangalore Bio, Bio Excellence Award – Biotech Services Sector

Best BioServices company of the year by Biospectrum

Acceptance of the clinical and bio-analytical facilities of CIL by the Department of Health & Human Services, FDA

Initiated operations in formulation development

Endo Pharmaceuticals and the Company collaborated to develop novel biological therapeutic molecules against cancer

Abbott and the Company collaborated to establish Abbott's nutrition research and development centre in India and the second R&D centre

Certification of the clinical facilities by ANVISA

Acquired 100% stake in Clinigene International Limited from Biocon

ISO 9001:2008 for contract research in drug discovery and contract manufacturing of biopharmaceuticals

AAALAC accreditation for conforming to the Guide for the Care and Use of Laboratory Animals and the Committee for the Purpose of Control and Supervision of Experiments on Animals guidelines”

Crossed an annual turnover of over `5,000 million in Financial Year 2013

Baxter International Inc. collaborated with the Company to establish the ‘Baxter Global Research Center’, the third dedicated R&D centre

Acceptance of the control testing laboratory by the Department of Health & Human Services, FDA

Bioservices - ABLE Tenth Anniversary Award – Outstanding contribution to Bioservices

Diamond sponsor recognition by the Association of Scientists of Indian Origin of the Society of Toxicology

Bristol-Myers Squibb and the Company extend collaboration for its dedicated R&D centre till 2020

Acceptance of the API manufacturing facility by the Department of Health & Human Services, FDA

Established a 75,000 sq.ft centre to provide stability and analytical services

ISO 14001:2004 for contract research in drug discovery and contract manufacturing of biopharmaceuticals

BS OHSAS 18001:2007 for contract research in drug discovery and contract manufacturing of biopharmaceuticals

Silver EDGE Award

EHS best practices award by CII

SAP Ace Award for special recognition for complex SAP implementation

Level I Laboratory certification issued by the NGSP to Clinigene International Limited

CIL was amalgamated with the Company

Awards, Recognitions and Accreditations :

Accreditation by the College of American Pathologists in relation to their laboratory accreditation program

Bangalore India Bio - Bio Excellence Award for outstanding contribution to the Biotech services sector

ISO 15189:2007 in the field of medical testing

Herbalife Nutrition Partners with Syngene to Establish Nutrition Research and Development Lab in India.

"Syngene International Announces Broadening of Research Collaboration with Amgen Inc." expands Dedicated R&D Center.

"Bristol-Myers Squibb and Syngene International Expand Ongoing Research Collaboration.".

Syngene signs R&D agreement with GSK.

"Syngene International Expands Collaboration with Baxter".

Best Bioprocessing Excellence Award 2018.

Bio-Excellence Award 2018.

"Syngene International wins CMO Leadership Awards presented by Life Science Leader Magazine".

India Pharma Award 2019.

Pharma and Chemical Manufacturing Category by National Safety Council of India (NSCI). Leadership Awards.

Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19.

Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing.

Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials.

Bioprocessing Excellence Award 2020.

Syngene receives India Pharma Awards 2021.

Syngene Ranked As One Of The Top 100 Indian Wealth Creators For 2021.

Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030.

Syngene through Biocon Foundation partners with NIMHANS for BHUMI.

Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing.

Syngene signs 10-year biologics manufacturing agreement with leading animal health company.

Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects.

Winner of India’s Best Managed Companies 2023 programme

Supply Chain Champion Award, 2023

Best Overall Sustainable Performance (Pharmaceutical) 2023

Biopharma Excellence Award (India Edition) 2023

Panbela announces issuance of new patent in Australia. Patent is for claims of a novel process for the production of SBP-101